rs870124

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022114.4(PRDM16):​c.1597T>C​(p.Ser533Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.855 in 1,611,306 control chromosomes in the GnomAD database, including 590,885 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S533L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.89 ( 60967 hom., cov: 30)
Exomes 𝑓: 0.85 ( 529918 hom. )

Consequence

PRDM16
NM_022114.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.03

Publications

34 publications found
Variant links:
Genes affected
PRDM16 (HGNC:14000): (PR/SET domain 16) The reciprocal translocation t(1;3)(p36;q21) occurs in a subset of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This gene is located near the 1p36.3 breakpoint and has been shown to be specifically expressed in the t(1:3)(p36,q21)-positive MDS/AML. The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal PR domain. The translocation results in the overexpression of a truncated version of this protein that lacks the PR domain, which may play an important role in the pathogenesis of MDS and AML. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
PRDM16 Gene-Disease associations (from GenCC):
  • left ventricular noncompaction 8
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • left ventricular noncompaction
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.779954E-7).
BP6
Variant 1-3411794-T-C is Benign according to our data. Variant chr1-3411794-T-C is described in ClinVar as Benign. ClinVar VariationId is 227026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRDM16NM_022114.4 linkc.1597T>C p.Ser533Pro missense_variant Exon 9 of 17 ENST00000270722.10 NP_071397.3 Q9HAZ2-1
PRDM16NM_199454.3 linkc.1597T>C p.Ser533Pro missense_variant Exon 9 of 17 NP_955533.2 Q9HAZ2-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRDM16ENST00000270722.10 linkc.1597T>C p.Ser533Pro missense_variant Exon 9 of 17 1 NM_022114.4 ENSP00000270722.5 Q9HAZ2-1

Frequencies

GnomAD3 genomes
AF:
0.893
AC:
135624
AN:
151882
Hom.:
60900
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.970
Gnomad AMI
AF:
0.775
Gnomad AMR
AF:
0.891
Gnomad ASJ
AF:
0.846
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.954
Gnomad FIN
AF:
0.916
Gnomad MID
AF:
0.880
Gnomad NFE
AF:
0.834
Gnomad OTH
AF:
0.900
GnomAD2 exomes
AF:
0.890
AC:
219507
AN:
246742
AF XY:
0.888
show subpopulations
Gnomad AFR exome
AF:
0.973
Gnomad AMR exome
AF:
0.923
Gnomad ASJ exome
AF:
0.853
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.913
Gnomad NFE exome
AF:
0.835
Gnomad OTH exome
AF:
0.869
GnomAD4 exome
AF:
0.851
AC:
1241375
AN:
1459306
Hom.:
529918
Cov.:
68
AF XY:
0.853
AC XY:
619472
AN XY:
726020
show subpopulations
African (AFR)
AF:
0.975
AC:
32631
AN:
33476
American (AMR)
AF:
0.919
AC:
41075
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.851
AC:
22202
AN:
26100
East Asian (EAS)
AF:
1.00
AC:
39678
AN:
39692
South Asian (SAS)
AF:
0.946
AC:
81604
AN:
86220
European-Finnish (FIN)
AF:
0.913
AC:
46930
AN:
51402
Middle Eastern (MID)
AF:
0.904
AC:
5211
AN:
5762
European-Non Finnish (NFE)
AF:
0.828
AC:
920144
AN:
1111604
Other (OTH)
AF:
0.860
AC:
51900
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
11209
22417
33626
44834
56043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21038
42076
63114
84152
105190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.893
AC:
135751
AN:
152000
Hom.:
60967
Cov.:
30
AF XY:
0.900
AC XY:
66865
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.970
AC:
40261
AN:
41486
American (AMR)
AF:
0.892
AC:
13641
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.846
AC:
2933
AN:
3468
East Asian (EAS)
AF:
0.999
AC:
5117
AN:
5124
South Asian (SAS)
AF:
0.953
AC:
4582
AN:
4808
European-Finnish (FIN)
AF:
0.916
AC:
9698
AN:
10588
Middle Eastern (MID)
AF:
0.891
AC:
262
AN:
294
European-Non Finnish (NFE)
AF:
0.834
AC:
56653
AN:
67916
Other (OTH)
AF:
0.901
AC:
1897
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
713
1426
2139
2852
3565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.854
Hom.:
114150
Bravo
AF:
0.892
TwinsUK
AF:
0.838
AC:
3107
ALSPAC
AF:
0.841
AC:
3240
ESP6500AA
AF:
0.967
AC:
3759
ESP6500EA
AF:
0.836
AC:
6902
ExAC
AF:
0.890
AC:
107324
Asia WGS
AF:
0.978
AC:
3401
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ser533Pro in exon 9 of PRDM16: This variant is not expected to have clinical sig nificance because it has been identified in 16.4% (1358/8260) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs870124). -

Sep 09, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Left ventricular noncompaction 8 Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.045
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
14
DANN
Benign
0.66
DEOGEN2
Benign
0.0039
T;.;.;T;.
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.059
N
LIST_S2
Benign
0.43
T;T;T;T;T
MetaRNN
Benign
5.8e-7
T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.7
.;N;.;N;.
PhyloP100
2.0
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
1.3
N;N;N;N;N
REVEL
Benign
0.089
Sift
Benign
0.65
T;T;T;T;T
Sift4G
Benign
0.45
T;T;T;T;T
Polyphen
0.0
.;B;.;B;.
Vest4
0.035
MPC
0.44
ClinPred
0.0027
T
GERP RS
5.3
Varity_R
0.096
gMVP
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs870124; hg19: chr1-3328358; COSMIC: COSV54612185; API